Dr. Martha Bishop Pitman (USA) is Director of the Cytopathology Laboratory at Massachusetts General Hospital and Professor of Pathology at Harvard Medical School. Dr. Pitman is an internationally recognized expert in the field of cytopathology in general, and pancreaticobiliary cytopathology in particular. Her contributions to the field have centered on the value of cytology in preoperative diagnosis of premalignant pancreatic lesions at high-risk for malignancy. She led an international and multidisciplinary group of physicians in the development of the Papanicolaou Society of Cytopathology Pancreaticobiliary Guidelines, and developed a terminology scheme for pancreaticobiliary cytology that classifies cytological interpretations in a manner that correlates diagnosis with risk of malignancy and evolving patient management options. She has held many leadership positions in national and international cytopathology organizations, including President of the Papanicolaou Society of Cytopathology.
Dr. Eva Darai-Ramqvist (Sweden) is a lecturer in Pathology at the Karolinska Institute, Stockholm and an expert in the field of cytology with special a interest in breast cytopathology. She is a member and treasurer of the Swedish Society of Clinical Cytology and is the chairman of the Swedish Working Group of FNA Cytology. She has numerous scientific publications with special interest in genomic instability of solid tumors. She is involved in implementing Artificaial Inteligence-based methods and developing screening programs in oral cancer.
Dr. Katalin Dobra (Sweden) is Associate Professor and Senior Lecturer in Molecular Pathology at the Karolinska Institutet. She is experienced in all aspects of cytology with particular focus on lung-cancer and malignant mesothelioma. In this field she has published several book chapters and numerous scientific articles ranging from basic research, to translational studies and predictive biomarker analyses. Katalin has established a new Cytology program for Cytotechnicians and she is involved in education of graduate students and residents in pathology.
Dr. Anders Hjerpe (Sweden) is Senior Professor at the Karolinska Institutet. He started his career as a student of Magnus Nasiell already in the early 1960ies, and he has been involved in Swedish cytology ever since. He is still active in clinical diagnostic work with main responsibility for exfoliative cytology at the Karolinska University Laboratory, Stockholm. Anders has published some 200 papers, also covering gycecological cytology, lung cytology and effusion cytology. On request by IMIG (international Mesothelioma Interest Group) he edited in 2015 the guidelines for diagnosis malignant mesothelioma based on effusion cytology.
Dr. Mats Ehinger (Sweden) is Director of the Hematopathological Unit at the Department of Pathology at Skåne University Hospital and Associate Professor of Hematopathology at Lund University. He is a recognized expert in the field of hematopathology including cytology of lymphomas and has arranged numerous courses in hematopathology at the national level. He is currently Chairman of the Swedish Working Group of Hematopathology, Vice-President and Treasurer of the Swedish Society of Pathology and an active member or the European Bone Marrow Working Group.
Dr. Eva Wojcik (USA) is currently the Chair of the Department of Pathology and Laboratory Medicine, and endowed Professor of Pathology and Urology. She is a renowned pathologist who has a special interest in genito-urinary cytopathology. Dr. Wojcik is certified in Anatomic Pathology and Clinical Pathology as well as Cytopathology by the American Board of Pathology. Dr. Wojcik is a Past President of the American Society of Cytopathology and an Associate Editor of the Journal of the American Society of Cytopathology. She serves on editorial boards of Diagnostic Cytopathology, American Journal of Surgical Pathology: Reviews and Reports and Archives of Pathology and Laboratory Medicine. Dr. Wojcik has been a frequent invited speaker at numerous international, national and regional forums. Most of her presentations are dealing with recent advances in urine cytology. She led international efforts to standardize reporting of urinary cytology that culminated with publication of The Paris System for Reporting Urinary Cytology. She has authored and co-authored over two hundreds articles, book chapters and abstracts.
Dr. Henryk Adam Domanski (Sweden) is Director of Cytolopathology and Immunohistochemistry at the Department of Pathology at Skåne University Hospital and Associate Professor of Pathology at Lund University. He is a recognized expert in the field of cytopathology general and soft tissue and bone cytopathology and pathology in particular. Dr Domanski has arranged numerous courses in cytopathology at the national and international levels. He is currently Member of the Swedish Working Group of FNA Cytology and Vice-President of the Swedish Society of Clinical Cytology.